Researchers at Carnegie Mellon University report
findings on an advanced nanomaterial-based biosensing platform that
detects, within seconds, antibodies specific to SARS-CoV-2, the
virus responsible for the COVID-19 pandemic. In addition to
testing, the platform will help to quantify patient immunological
response to the new vaccines with precision.
If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!
The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.
If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!
The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.
